Scopus BioPharma (SCPS) News Today → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free SCPS Stock Alerts $0.0021 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | benzinga.comArgent Biopharma Stock (OTC:MGCLF), Quotes and News SummaryFebruary 14, 2024 | uk.investing.comScopus Biopharma Inc (SCPS)February 7, 2024 | morningstar.comArriVent BioPharma Inc AVBPJanuary 31, 2024 | finance.yahoo.comScopus BioPharma Inc. (SCPS)January 8, 2024 | msn.com7+ Companies That Had Their IPO in 2020: Best and Worst PerformersNovember 7, 2023 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of CancerNovember 2, 2023 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerJuly 15, 2023 | morningstar.comKinnate Biopharma Inc Ordinary SharesMay 16, 2023 | benzinga.comScopus BioPharma Stock (OTC:SCPS), Insider Trading ActivityApril 19, 2023 | morningstar.comESG Industry Landscape Report: BiopharmaMarch 18, 2023 | benzinga.comYS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQDecember 16, 2022 | benzinga.comShort Volatility Alert: Scopus Biopharma IDecember 15, 2022 | msn.comWhy Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving PremarketNovember 10, 2022 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerOctober 18, 2022 | finance.yahoo.comScopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueMay 5, 2022 | finance.yahoo.comScopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsMarch 22, 2022 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitJanuary 10, 2022 | finance.yahoo.comScopus BioPharma Provides Update Following Annual Meeting of StockholdersJanuary 6, 2022 | finance.yahoo.comDR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSDecember 28, 2021 | nasdaq.comScopus Biopharma Inc Shares Approach 52-Week Low - Market MoverDecember 17, 2021 | finance.yahoo.comScopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyDecember 7, 2021 | finance.yahoo.comScopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardDecember 6, 2021 | finance.yahoo.comDr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingNovember 22, 2021 | finance.yahoo.comScopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketOctober 8, 2021 | finance.yahoo.comScopus BioPharma Announces Adjournment of Annual Meeting of StockholdersOctober 5, 2021 | finance.yahoo.comScopus BioPharma to Present at the LD Micro Main EventOctober 1, 2021 | finance.yahoo.comScopus BioPharma Retaining Counsel to Investigate Unusual Market ActivityOctober 1, 2021 | finance.yahoo.comScopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas ConferenceSeptember 29, 2021 | finance.yahoo.comScopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 28, 2021 | apnews.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the ...September 28, 2021 | finance.yahoo.comScopus BioPharma to Adjourn 2021 Annual Meeting of StockholdersSeptember 28, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 23, 2021 | finance.yahoo.comScopus BioPharma to Present at the Benzinga Healthcare Small Cap ConferenceSeptember 21, 2021 | finance.yahoo.comChina National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet PlatformSeptember 20, 2021 | finance.yahoo.comDr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual MeetingSeptember 14, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory BoardSeptember 9, 2021 | finance.yahoo.comScopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 9, 2021 | marketwatch.comScopus BioPharma's Subsidiary -- Duet Therapeutics -- Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 8, 2021 | apnews.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin ...September 7, 2021 | stockhouse.comScopus BioPharma's Subsidiary - Duet Therapeutics - Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 7, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific AdvisorSeptember 4, 2021 | stockhouse.comScopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 14th Annual RNA Consortium MeetingSeptember 3, 2021 | benzinga.comScopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium MeetingSeptember 3, 2021 | apnews.comScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA ...September 3, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium MeetingSeptember 2, 2021 | finance.yahoo.comScopus BioPharma Launches Duet TherapeuticsSeptember 2, 2021 | marketbeat.comTrading was temporarily halted for "SCPS" at 09:09 AM with a stated reason of "LULD pause."August 4, 2021 | marketbeat.comTrading was temporarily halted for "SCPS" at 03:08 AM with a stated reason of "LULD pause."July 25, 2021 | barrons.comScopus BioPharma Inc. Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Email Address He cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto. Click now for the best way into the newest AI projects SCPS Media Mentions By Week SCPS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPS News Sentiment▼0.000.55▲Average Medical News Sentiment SCPS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPS Articles This Week▼00▲SCPS Articles Average Week Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Statera Biopharma News Today Calithera Biosciences News Today Bruush Oral Care News Today Humanigen News Today Context Therapeutics News Today Grifols News Today LAVA Therapeutics News Today Mainz Biomed News Today NLS Pharmaceutics News Today Pharvaris News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.